title: Design-related risk factors for revision of primary cemented stems.
abstract: OBJECTIVE
  Even small design variables of the femoral stem may influence the outcome of a hip arthroplasty. We investigated whether design-related factors play any role in the risk of non-aseptic revision of the 3 most frequently used primary cemented stem designs in the Swedish Hip Arthroplasty Register.
  
  
  METHODS
  We studied 71,184 primary cemented femoral stem implants (21,008 Exeter polished stems, 43,036 Lubinus SPII stems, and 7,140 Spectron EF Primary stems) that were inserted from 1999 through 2006. Design-specific characteristics were analyzed using separate Cox regression models that were adjusted for sex, age, diagnosis, incision, and number of operations (first vs. second).
  
  
  RESULTS
  The crude revision rate varied between 0.8% (Lubinus SPII) and 1.4% (Spectron Primary). For the Exeter stem, the smallest femoral head diameter (22 mm) was associated with a higher risk of revision. No other design-specific parameters influenced the risk of revision of the Exeter stem. The smallest Lubinus stem size, a stem with extended neck length combined with a femoral head with increasing neck length, or the use of a cobalt-chromium head had a negative influence on the outcome. For the Spectron stem, the risk of revision was elevated for the smallest stem and for increasing offset calculated as the combined effect of high offset design and increasing neck length.
  
  
  CONCLUSIONS
  Overall revision rates were low, but for two of the stems studied design factors such as size and neck length or offset influenced the risk of non-aseptic revision.
authors.affiliation: Department of Orthopaedics, Institute of Clinical Sciences at Sahlgrenska Academy, University of Gothenburg, Sweden. truike.thien@vgregion.se
authors.forename: Truike M
authors.initials: TM
authors.lastname: Thien
authors.forename: Johan
authors.initials: J
authors.lastname: Kärrholm
mesh_terms: D000328:Adult; D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects*; D002484:Cementation; D005260:Female; D005500:Follow-Up Studies; D006622:Hip Prosthesis / Q000009:adverse effects; D006801:Humans; D008297:Male; D011474:Prosthesis Design; D011475:Prosthesis Failure; D012086:Reoperation; D012307:Risk Factors; D016896:Treatment Outcome